Association between increased N-terminal pro-brain natriuretic peptide level and poor clinical outcomes after acute ischemic stroke

[1]  Tan Xu,et al.  Antiphosphatidylserine Antibodies and Clinical Outcomes in Patients With Acute Ischemic Stroke , 2016, Stroke.

[2]  N. Mickuvienė,et al.  Role of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Inteleukin-6 in Predicting a Poor Outcome after a Stroke , 2015, Neuroimmunomodulation.

[3]  Natalia S. Rost,et al.  B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis: Pooled Data Meta-Analysis , 2015, Stroke.

[4]  Yilong Wang,et al.  Associations Between Estimated Glomerular Filtration Rate and Stroke Outcomes in Diabetic Versus Nondiabetic Patients , 2014, Stroke.

[5]  Haiqing Yan,et al.  N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke , 2014, Neuroreport.

[6]  V. Howard,et al.  N-Terminal Pro–B-type Natriuretic Peptide and Stroke Risk: The Reasons for Geographic and Racial Differences in Stroke Cohort , 2014, Stroke.

[7]  J. Chen,et al.  Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. , 2014, JAMA.

[8]  A. Folsom,et al.  Troponin T, N-Terminal Pro–B-Type Natriuretic Peptide, and Incidence of Stroke: The Atherosclerosis Risk in Communities Study , 2013, Stroke.

[9]  M. Endres,et al.  Frequency, determinants and outcome of elevated troponin in acute ischemic stroke patients. , 2012, International journal of cardiology.

[10]  Vladimir Hachinski,et al.  Cardiovascular and neurological causes of sudden death after ischaemic stroke , 2012, The Lancet Neurology.

[11]  S. Sethi,et al.  GFR estimating equations in a multiethnic Asian population. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  I. Idris,et al.  N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute stroke. , 2010, Age and ageing.

[13]  A. Maisel,et al.  Natriuretic peptides. , 2007, Journal of the American College of Cardiology.

[14]  M. Vassallo,et al.  N-terminal proBrain natriuretic peptide levels predict short-term poststroke survival. , 2006, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[15]  J. Salonen,et al.  Clinical Research Prevention and Epidemiology Plasma N-terminal Fragments of Natriuretic Propeptides Predict the Risk of Cardiovascular Events and Mortality in Middle-aged Men , 2022 .

[16]  Z. Arıtürk,et al.  Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. , 2006, American heart journal.

[17]  Cheuk-Kwan Sun,et al.  Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[18]  B. Drew,et al.  Acute Neurocardiogenic Injury After Subarachnoid Hemorrhage , 2005, Circulation.

[19]  G. Louridas,et al.  N-Terminal Pro-Brain Natriuretic Peptide Levels Are Elevated in Patients with Acute Ischemic Stroke , 2005, Angiology.

[20]  A. Dobson,et al.  How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review , 2005, BMJ : British Medical Journal.

[21]  T. Etgen,et al.  Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide in Acute Ischemic Stroke Do Not Relate to Clinical Prognosis , 2005, Stroke.

[22]  Daniel W. Jones,et al.  Recommendations for Blood Pressure Measurement in Humans: An AHA Scientific Statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee , 2005, Journal of clinical hypertension.

[23]  H. White,et al.  N-Terminal Pro–B-Type Natriuretic Peptide Levels for Dynamic Risk Stratification of Patients With Acute Coronary Syndromes , 2004, Circulation.

[24]  D. Ardissino,et al.  N-Terminal Pro-Brain Natriuretic Peptide on Admission Has Prognostic Value Across the Whole Spectrum of Acute Coronary Syndromes , 2004, Circulation.

[25]  J. Soustiel,et al.  Role of brain natriuretic peptide in cerebral vasospasm , 2003, Acta Neurochirurgica.

[26]  M. Drazner,et al.  B-type natriuretic peptide in cardiovascular disease , 2003, The Lancet.

[27]  S. Oparil.  Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Practical Implications , 2003, Hypertension.

[28]  Douglas W Mahoney,et al.  Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.

[29]  R. Doughty,et al.  Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment , 1997, Clinical endocrinology.

[30]  H. Itoh,et al.  Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. , 1997, American heart journal.

[31]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[32]  Xingyong Chen,et al.  The prognostic value of combined NT-pro-BNP levels and NIHSS scores in patients with acute ischemic stroke. , 2012, Internal medicine.